FDA Clears Quidel's MDx for Bordetella Pertussis | GenomeWeb

NEW YORK (GenomeWeb) – Quidel said after the close of the market on Wednesday that the US Food and Drug Administration has cleared the company's AmpliVue Bordetella Assay. 

The assay detects Bordetella pertussis nucleic acids isolated from nasopharyngeal swab specimens from patients suspected of having a respiratory tract infection due to the bacteria, which causes whooping cough. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.